Copyright Reports & Markets. All rights reserved.

Global Factor VIII Deficiency Treatment Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Factor VIII Deficiency Treatment

      • 1.1 Definition of Factor VIII Deficiency Treatment
      • 1.2 Factor VIII Deficiency Treatment Segment by Type
        • 1.2.1 Global Factor VIII Deficiency Treatment Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Prophylaxis
        • 1.2.3 On-demand
        • 1.2.4 Inhibitor
      • 1.3 Factor VIII Deficiency Treatment Segment by Applications
        • 1.3.1 Global Factor VIII Deficiency Treatment Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hemophilia A drugs
        • 1.3.3 Hemophilia A inhibitors treatment
        • 1.3.4 Von Willebrand disease treatment
      • 1.4 Global Factor VIII Deficiency Treatment Overall Market
        • 1.4.1 Global Factor VIII Deficiency Treatment Revenue (2014-2025)
        • 1.4.2 Global Factor VIII Deficiency Treatment Production (2014-2025)
        • 1.4.3 North America Factor VIII Deficiency Treatment Status and Prospect (2014-2025)
        • 1.4.4 Europe Factor VIII Deficiency Treatment Status and Prospect (2014-2025)
        • 1.4.5 China Factor VIII Deficiency Treatment Status and Prospect (2014-2025)
        • 1.4.6 Japan Factor VIII Deficiency Treatment Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Factor VIII Deficiency Treatment Status and Prospect (2014-2025)
        • 1.4.8 India Factor VIII Deficiency Treatment Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Factor VIII Deficiency Treatment
      • 2.3 Manufacturing Process Analysis of Factor VIII Deficiency Treatment
      • 2.4 Industry Chain Structure of Factor VIII Deficiency Treatment

      3 Development and Manufacturing Plants Analysis of Factor VIII Deficiency Treatment

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Factor VIII Deficiency Treatment Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Factor VIII Deficiency Treatment
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Factor VIII Deficiency Treatment Production and Capacity Analysis
      • 4.2 Factor VIII Deficiency Treatment Revenue Analysis
      • 4.3 Factor VIII Deficiency Treatment Price Analysis
      • 4.4 Market Concentration Degree

      5 Factor VIII Deficiency Treatment Regional Market Analysis

      • 5.1 Factor VIII Deficiency Treatment Production by Regions
        • 5.1.1 Global Factor VIII Deficiency Treatment Production by Regions
        • 5.1.2 Global Factor VIII Deficiency Treatment Revenue by Regions
      • 5.2 Factor VIII Deficiency Treatment Consumption by Regions
      • 5.3 North America Factor VIII Deficiency Treatment Market Analysis
        • 5.3.1 North America Factor VIII Deficiency Treatment Production
        • 5.3.2 North America Factor VIII Deficiency Treatment Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Factor VIII Deficiency Treatment Import and Export
      • 5.4 Europe Factor VIII Deficiency Treatment Market Analysis
        • 5.4.1 Europe Factor VIII Deficiency Treatment Production
        • 5.4.2 Europe Factor VIII Deficiency Treatment Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Factor VIII Deficiency Treatment Import and Export
      • 5.5 China Factor VIII Deficiency Treatment Market Analysis
        • 5.5.1 China Factor VIII Deficiency Treatment Production
        • 5.5.2 China Factor VIII Deficiency Treatment Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Factor VIII Deficiency Treatment Import and Export
      • 5.6 Japan Factor VIII Deficiency Treatment Market Analysis
        • 5.6.1 Japan Factor VIII Deficiency Treatment Production
        • 5.6.2 Japan Factor VIII Deficiency Treatment Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Factor VIII Deficiency Treatment Import and Export
      • 5.7 Southeast Asia Factor VIII Deficiency Treatment Market Analysis
        • 5.7.1 Southeast Asia Factor VIII Deficiency Treatment Production
        • 5.7.2 Southeast Asia Factor VIII Deficiency Treatment Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Factor VIII Deficiency Treatment Import and Export
      • 5.8 India Factor VIII Deficiency Treatment Market Analysis
        • 5.8.1 India Factor VIII Deficiency Treatment Production
        • 5.8.2 India Factor VIII Deficiency Treatment Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Factor VIII Deficiency Treatment Import and Export

      6 Factor VIII Deficiency Treatment Segment Market Analysis (by Type)

      • 6.1 Global Factor VIII Deficiency Treatment Production by Type
      • 6.2 Global Factor VIII Deficiency Treatment Revenue by Type
      • 6.3 Factor VIII Deficiency Treatment Price by Type

      7 Factor VIII Deficiency Treatment Segment Market Analysis (by Application)

      • 7.1 Global Factor VIII Deficiency Treatment Consumption by Application
      • 7.2 Global Factor VIII Deficiency Treatment Consumption Market Share by Application (2014-2019)

      8 Factor VIII Deficiency Treatment Major Manufacturers Analysis

      • 8.1 Bayer HealthCare
        • 8.1.1 Bayer HealthCare Factor VIII Deficiency Treatment Production Sites and Area Served
        • 8.1.2 Bayer HealthCare Product Introduction, Application and Specification
        • 8.1.3 Bayer HealthCare Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 CSL
        • 8.2.1 CSL Factor VIII Deficiency Treatment Production Sites and Area Served
        • 8.2.2 CSL Product Introduction, Application and Specification
        • 8.2.3 CSL Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Grifols
        • 8.3.1 Grifols Factor VIII Deficiency Treatment Production Sites and Area Served
        • 8.3.2 Grifols Product Introduction, Application and Specification
        • 8.3.3 Grifols Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Novo Nordisk
        • 8.4.1 Novo Nordisk Factor VIII Deficiency Treatment Production Sites and Area Served
        • 8.4.2 Novo Nordisk Product Introduction, Application and Specification
        • 8.4.3 Novo Nordisk Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Pfizer
        • 8.5.1 Pfizer Factor VIII Deficiency Treatment Production Sites and Area Served
        • 8.5.2 Pfizer Product Introduction, Application and Specification
        • 8.5.3 Pfizer Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Shire
        • 8.6.1 Shire Factor VIII Deficiency Treatment Production Sites and Area Served
        • 8.6.2 Shire Product Introduction, Application and Specification
        • 8.6.3 Shire Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Alnylam Pharmaceuticals
        • 8.7.1 Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Production Sites and Area Served
        • 8.7.2 Alnylam Pharmaceuticals Product Introduction, Application and Specification
        • 8.7.3 Alnylam Pharmaceuticals Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Amarna Therapeutics
        • 8.8.1 Amarna Therapeutics Factor VIII Deficiency Treatment Production Sites and Area Served
        • 8.8.2 Amarna Therapeutics Product Introduction, Application and Specification
        • 8.8.3 Amarna Therapeutics Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Biogen Idec
        • 8.9.1 Biogen Idec Factor VIII Deficiency Treatment Production Sites and Area Served
        • 8.9.2 Biogen Idec Product Introduction, Application and Specification
        • 8.9.3 Biogen Idec Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 BioMarin Pharmaceutical
        • 8.10.1 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Production Sites and Area Served
        • 8.10.2 BioMarin Pharmaceutical Product Introduction, Application and Specification
        • 8.10.3 BioMarin Pharmaceutical Factor VIII Deficiency Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Catalyst Biosciences

      9 Development Trend of Analysis of Factor VIII Deficiency Treatment Market

      • 9.1 Global Factor VIII Deficiency Treatment Market Trend Analysis
        • 9.1.1 Global Factor VIII Deficiency Treatment Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Factor VIII Deficiency Treatment Regional Market Trend
        • 9.2.1 North America Factor VIII Deficiency Treatment Forecast 2019-2025
        • 9.2.2 Europe Factor VIII Deficiency Treatment Forecast 2019-2025
        • 9.2.3 China Factor VIII Deficiency Treatment Forecast 2019-2025
        • 9.2.4 Japan Factor VIII Deficiency Treatment Forecast 2019-2025
        • 9.2.5 Southeast Asia Factor VIII Deficiency Treatment Forecast 2019-2025
        • 9.2.6 India Factor VIII Deficiency Treatment Forecast 2019-2025
      • 9.3 Factor VIII Deficiency Treatment Market Trend (Product Type)
      • 9.4 Factor VIII Deficiency Treatment Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Factor VIII Deficiency Treatment Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Factor VIII Deficiency Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Factor VIII Deficiency Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Factor VIII Deficiency Treatment market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Factor VIII Deficiency Treatment in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Factor VIII Deficiency Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Bayer HealthCare
        CSL
        Grifols
        Novo Nordisk
        Pfizer
        Shire
        Alnylam Pharmaceuticals
        Amarna Therapeutics
        Biogen Idec
        BioMarin Pharmaceutical
        Catalyst Biosciences

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Prophylaxis
        On-demand
        Inhibitor

        Segment by Application
        Hemophilia A drugs
        Hemophilia A inhibitors treatment
        Von Willebrand disease treatment

        Buy now